Search Filters

Search Results

Found 1079 results

510(k) Data Aggregation

    K Number
    K252557

    Validate with FDA (Live)

    Date Cleared
    2025-12-22

    (131 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K250959

    Validate with FDA (Live)

    Device Name
    BioticsAI
    Manufacturer
    Date Cleared
    2025-12-22

    (266 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K250791

    Validate with FDA (Live)

    Date Cleared
    2025-12-04

    (265 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K251601

    Validate with FDA (Live)

    Date Cleared
    2025-12-03

    (190 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K253310

    Validate with FDA (Live)

    Manufacturer
    Date Cleared
    2025-11-25

    (57 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The multifunctional ultrasound scanner is used to collect, display, and analyze ultrasound images during ultrasound imaging procedures in combination with supported echographic probes.

    Main applications

    • Cardiac
      • Districts: Cardiac Adult, Cardiac Pediatric (including newborns)
      • Invasive access: Transesophageal
    • Vascular
      • Districts: Neonatal, Adult Cephalic, Vascular
      • Invasive access: Not applicable
    • General Imaging
      • Districts: Abdominal, Musculo-skeletal, Neonatal, Pediatric, Small Organ (Testicles, Breast, Thyroid), Urologic
      • Invasive access: Intraoperative (Abdominal), Laparoscopic, Transrectal
    • Women Health
      • Districts: OB/Fetal, Gynecology
      • Invasive access: Transrectal, Transvaginal

    The primary modes of operation are: B-Mode, M-Mode, Tissue Enhancement Imaging (TEI), Multi View (MView), Doppler (both PW and CW), Color Flow Mapping (CFM), Power Doppler, Tissue Velocity Mapping (TVM), Combined modes, Elastosonography, 3D/4D and CnTI.

    The ultrasound scanner is suitable for use in health institutions and is designed for ultrasound practitioners.

    Device Description

    7600 Ultrasound System is a portable based ultrasound device used to perform diagnostic general ultrasound studies.

    7600 Ultrasound System is equipped with two LCD Color Displays. The first LCD Color Display is the main output device used to display the acquisition image, the acquisition configuration and the exam results. The second LCD is provided with Touch panel and is used as a flexible input control device because its easy configurability.

    The device uses the physical properties of the ultrasound (i.e. sound waves with frequency above 20 kHz and that are not audible to the human ear) for the visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues and of the Doppler effect, i.e. the frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream, to determine both direction and velocity of blood flow in the target organs.

    The primary modes of operation are: B-Mode, M-Mode, Tissue Enhancement Imaging (TEI), Multi View (MView), Doppler (both PW and CW), Color Flow Mapping (CFM), Power Doppler, Tissue Velocity Mapping (TVM), Combined modes. 7600 Ultrasound System also manages Elastosonography, 3D/4D and CnTI.

    Several types of probes are used to cover different needs in terms of geometrical shape and frequency range.

    7600 Ultrasound System can drive Phased array, Convex array, Linear array, Doppler probes and Volumetric probes (Bi-Scan probes).

    7600 Ultrasound System is equipped with wireless capability.

    7600 Ultrasound System will be available on the market in two models with the following commercial names: MyLabC25, MyLabC30.

    The difference between MyLabC25 and MyLabC30 models is only in the licenses configuration.

    7600 Ultrasound System, defined herein, is a new portable version of the cart-based 6600 Ultrasound System previously cleared under K243253.

    The proposed 7600 Ultrasound System includes a new software version that combines features FDA-cleared and already available in the predicate and reference devices (K243253 and K241671). No new functionalities have been introduced in the current software release compared to the version previously cleared.

    7600 Ultrasound System employs the same fundamental technological characteristics as its predicate device cleared via K243253.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K252328

    Validate with FDA (Live)

    Date Cleared
    2025-11-24

    (122 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is a general purpose ultrasound system intended for use by qualified and trained healthcare professionals. Specific clinical applications remain the same as previously cleared: Fetal/OB; Abdominal (including GYN, pelvic and infertility monitoring/follicle development); Pediatric; Small Organ (breast, testes, thyroid etc.); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Musculo-skeletal Conventional and Superficial; Vascular; Transvaginal (including GYN); Transrectal

    Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Coded Pulse, 3D/4D Imaging mode, Elastography, Shear Wave Elastography and Combined modes: B/M, B/Color, B/PWD, B/Color/PWD, B/Power/ PWD, B/Elastography. The Voluson™ Expert 18, Voluson™ Expert 20, Voluson™ Expert 22 is intended to be used in a hospital or medical clinic.

    Device Description

    The systems are full-featured Track 3 ultrasound systems, primarily for general radiology use and specialized for OB/GYN with particular features for real-time 3D/4D acquisition. They consist of a mobile console with keyboard control panel; color LCD/TFT touch panel, color video display and optional image storage and printing devices. They provide high performance ultrasound imaging and analysis and have comprehensive networking and DICOM capability. They utilize a variety of linear, curved linear, matrix phased array transducers including mechanical and electronic scanning transducers, which provide highly accurate real-time three-dimensional imaging supporting all standard acquisition modes.

    The following probes are the same as the predicate: RIC5-9-D, IC5-9-D, RIC6-12-D, 9L-D, 11L-D, ML6-15-D, RAB6-D, C1-6-D, C2-9-D, M5Sc-D, RM7C, eM6CG3, RSP6-16-D , RIC10-D, 6S-D and L18-18iD, RIC12-D.

    The existing cleared Probe C1-6-D is being added to previously cleared SW- AI Feature Sonolyst 1st Trimester.

    AI/ML Overview

    The provided text describes the FDA 510(k) clearance for the Voluson Expert Series ultrasound systems, specifically focusing on the AI feature "Sonolyst 1st Trimester" and the addition of the C1-6-D transducer to this feature.

    Here's an analysis of the acceptance criteria and the study that proves the device meets them:

    1. Table of Acceptance Criteria and Reported Device Performance

    FunctionalityAcceptance CriteriaReported Device Performance (CL2 probe group)
    SonoLystIR0.800.93
    SonoLystX0.800.84
    SonoLystLive0.700.84

    Additional Performance Data (Mean values across transabdominal and transvaginal scans):

    FunctionalityMean (%)
    SonoLyst IR94.1
    SonoLyst X92.4
    SonoLyst Live82.5

    2. Sample Sizes Used for the Test Set and Data Provenance

    • SonoLyst 1st Trim IR: 7970 images

    • SonoLyst 1st Trim X: 4931 images

    • SonoLyst 1st Trim Live: 9111 images

    • SonoBiometry CRL: 243 images

    • Specific to Probegroup CL2 (which includes C1-6-D Probe): Data was collected from 396 patients.

    • Data Provenance: Data was collected from multiple geographical sites including the UK, Austria, India, and USA. The data was collected using different systems (GE Voluson V730, P8, S6/S8, E6, E8, E10, Expert 22, Philips Epiq 7G).

    • Retrospective/Prospective: The document does not explicitly state whether the test data was retrospective or prospective. However, the mention of "data acquired with transabdominal vs transvaginal probes" and "patients within the dataset includes pregnancies between 11 and 14 weeks of gestation, with no known fetal abnormalities at the time of imaging" suggests that the images were pre-existing or collected specifically for this evaluation, implying a retrospective or a pre-defined prospective collection for the study.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    • Initial Curation: A single sonographer curated (sorted and graded) the images initially.
    • Review Panel for Graded Images: Where the system's grading differed from the initial ground truth, the images were reviewed by a 5-sonographer review panel to determine the grading accuracy of the system.
    • Qualifications: The document identifies them as "sonographers." Specific years of experience or expertise in fetal ultrasound are not provided, other than their role in image curation and review.

    4. Adjudication Method for the Test Set

    • Initial Sorting and Grading: Images were initially curated (sorted and graded) by a single sonographer.
    • Reclassification during Sorting: The SonoLyst IR/X First Trimester process resulted in some images being reclassified during sorting based on the majority view of the panel (after the step where the system had sorted them).
    • Grading Accuracy Review: For graded images where the initial single sonographer's ground truth differed from the system, a 5-sonographer review panel was used to determine the accuracy. This suggests an adjudication process where the panel formed a consensus or majority opinion to establish the final ground truth when discrepancies arose. The exact method (e.g., simple majority, weighted vote) is not specified beyond "majority view of the panel."

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    • The document does not indicate that a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was done to evaluate how much human readers improve with AI vs. without AI assistance. The testing focused on the standalone performance of the AI algorithm against a ground truth established by sonographers.
    • The verification of SonoLystLive 1st Trim Trimester features was based on the "average agreement between a sonographer panel and the output of the algorithm regarding Traffic light quality," which involves human readers assessing traffic light quality in relation to the algorithm's output, but it's not a study designed to measure human improvement with AI assistance.

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

    • Yes, a standalone performance evaluation was conducted. The performance metrics (SonoLystIR, SonoLystX, SonoLystLive, SonoBiometry CRL success rate) are reported as the accuracy of the algorithm comparing its output directly against the established ground truth. This is a measure of the algorithm's ability to perform its specified functions independently.

    7. The Type of Ground Truth Used

    • The ground truth was established through expert consensus/review by sonographers.
      • Initial curation by a single sonographer.
      • Review and reclassification during sorting based on the "majority view of the panel."
      • A 5-sonographer review panel was used to determine grading accuracy for discrepancies.
    • The ground truth also adhered to standardized imaging protocols based on internationally recognized guidelines (AIUM Practice Parameter, AIUM Detailed Protocol, ISUOG Practice Guidelines, ISUOG Detailed Protocol, and the study by Yimei Liao et al.) which informed the quality and consistency of the expert review.

    8. The Sample Size for the Training Set

    • 122,711 labelled source images from 35,861 patients were used for training.

    9. How the Ground Truth for the Training Set Was Established

    • The document states that "Data used for both training and validation has been collected across multiple geographical sites using different systems to represent the variations in target population."
    • While the specific method for establishing ground truth for the training set is not explicitly detailed in the same way as the test set, it can be inferred that similar expert labeling and curation processes would have been applied given the emphasis on "labelled source images." The document focuses on the test set truthing process as part of verification, implying that the training data would have undergone a robust labeling process to ensure quality for machine learning.
    Ask a Question

    Ask a specific question about this device

    K Number
    K253487

    Validate with FDA (Live)

    Date Cleared
    2025-11-17

    (27 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    ACUSON Maple
    The ACUSON Maple ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Abdominal, Obstetrics, Gynecology, Small Parts, Pediatric, Neonatal, Vascular, Urology, Echocardiography, Musculoskeletal, and Intraoperative applications using different ultrasound transducers for different applications. The system supports the Ultrasound-Derived Fat Fraction (UDFF) measurement tool to report an index that can be useful as an aid to a physician managing adult patients with hepatic steatosis. The system also provides the ability to measure anatomical structures and provides analysis packages that provide information used by a physician for clinical diagnostic purposes.

    The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and published in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with patients regarding the state of their cardiovascular system.

    ACUSON Maple Select
    The ACUSON Maple Select ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Abdominal, Obstetrics, Gynecology, Small Parts, Pediatric, Vascular, Urology, Echocardiography, and Musculoskeletal applications using different ultrasound transducers for different applications. The system also provides the ability to measure anatomical structures and provides analysis packages that provide information used by a physician for clinical diagnostic purposes.

    The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and published in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with patients regarding the state of their cardiovascular system.

    Device Description

    The ACUSON Maple Diagnostic Ultrasound System and ACUSON Maple Select Diagnostic Ultrasound System are multi-purpose, mobile, software-controlled, diagnostic ultrasound systems with an on-screen display for thermal and mechanical indices related to potential bio-effect mechanisms. Their function is to acquire harmonic ultrasound echo data and display it in B-Mode, M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Color M mode, Doppler Tissue Image mode, Amplitude Doppler Mode, combination modes, Harmonic Imaging and 3D Imaging modes, or Harmonic Imaging and 4D imaging modes on a flat panel display for diagnostic ultrasound imaging.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K253457

    Validate with FDA (Live)

    Date Cleared
    2025-11-13

    (38 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ACUSON Juniper ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Abdominal, Obstetrics, Gynecology, Small Parts, Pediatric, Neonatal, Vascular, Urology, Echocardiography, Musculoskeletal, and Intraoperative applications using different ultrasound transducers for different applications.

    The system supports the Ultrasound-Derived Fat Fraction (UDFF) measurement tool to report an index that can be useful as an aid to a physician managing adult patients with hepatic steatosis.

    The system also provides the ability to measure anatomical structures and provides analysis packages that provide information used by a physician for clinical diagnostic purposes.

    The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and published in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with patients regarding the state of their cardiovascular system.

    ACUSON Juniper Select

    The ACUSON Juniper Select ultrasound imaging system is intended to provide images of, or signals from, inside the body by an appropriately trained healthcare professional in a clinical setting for the following applications: Abdominal, Obstetrics, Gynecology, Small Parts, Pediatric, Vascular, Urology, Echocardiography, and Musculoskeletal applications using different ultrasound transducers for different applications.

    The system also provides the ability to measure anatomical structures and provides analysis packages that provide information used by a physician for clinical diagnostic purposes.

    The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and published in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with patients regarding the state of their cardiovascular system.

    Device Description

    The ACUSON Juniper Diagnostic Ultrasound System and ACUSON Juniper Select Diagnostic Ultrasound System are multi-purpose, mobile, software-controlled, diagnostic ultrasound systems with an on-screen display for thermal and mechanical indices related to potential bio-effect mechanisms. Their function is to acquire harmonic ultrasound echo data and display it in B-Mode, M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Color M mode, Doppler Tissue Image mode, Amplitude Doppler Mode, combination modes, Harmonic Imaging and 3D Imaging modes, or Harmonic Imaging and 4D imaging modes on a flat panel display for diagnostic ultrasound imaging.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Consona N5, Consona N5 Pro, Consona N5 Super, Consona N5 Exp, Consona ER, Consona N5S, Consona EI, Consona EF, Consona N5 Elite, Consona N5 Ultra, Consona N3, Consona N3 Exp Diagnostic Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in fetal, abdominal, pediatric, small organ(breast, thyroid, testes), neonatal cephalic, adult cephalic, trans-rectal, trans-vaginal, musculo-skeletal (conventional), musculo-skeletal (superficial), thoracic/ pleural, cardiac adult, cardiac pediatric, peripheral vessel and urology, intra-operative (abdominal, thoracic, and vascular) exams.

    This device is a general purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid, which is intended to be used in a hospital or medical clinic.

    Modes of operation include: B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode (B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, iScape View, TDI, Color M, Smart 3D, 4D(Real-time 3D), Strain Elastography, Contrast imaging (Contrast agent for LVO), Contrast imaging (Contrast agent for Liver).

    Device Description

    The Consona N5, Consona N5 Pro, Consona N5 Super, Consona N5 Exp, Consona ER, Consona N5S, Consona EI, Consona EF, Consona N5 Elite, Consona N5 Ultra, Consona N3, Consona N3 Exp Diagnostic Ultrasound System is a general purpose, mobile, software controlled, ultrasonic diagnostic system. Its function is to acquire and display ultrasound images.

    Modes of operation include: B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode (B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, iScape View, TDI, Color M, Smart 3D, 4D(Real-time 3D), Strain Elastography, Contrast imaging (Contrast agent for LVO), Contrast imaging (Contrast agent for Liver).

    The Consona N5, Consona N5 Pro, Consona N5 Super, Consona N5 Exp, Consona ER, Consona N5S, Consona EI, Consona EF, Consona N5 Elite, Consona N5 Ultra, Consona N3, Consona N3 Exp Diagnostic Ultrasound System can also measure anatomical structures and offer analysis packages to provide information based on which the competent health care professionals can make the diagnosis.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    Page 1 of 108